We have studied the effect of changes in shear stress on diameter of isolated arterioles of rat cremaster muscle. The steady-state active diameter of arterioles at a constant perfusion pressure (60 mm Hg) was 80± 1.2 gm. The vessels' passive diameter (Ca2`-free solution) was 156±1.8 ,um. Changes in shear stress were induced either by an increase in flow (velocity) or by an increase in viscosity of the perfusion solution. At a constant perfusion pressure, the stepwise increase in perfusion flow (0-80 ,l/min in 10-,ul/min steps) elicited, with a delay of "'20 seconds, a gradual increase in diameter up to 46%. At a constant 20-,l/min flow rate, increases in viscosity of the perfusate (2%, 4%, and 6% dextran [molecular weight, 77,800]) caused a gradual vasodilation up to 22%. Varying flow and viscosity of the perfusate simultaneously resulted in an upward shift of the flow-diameter curve. Both flowand viscosity-induced dilations were eliminated by the removal of the endothelium of arterioles (by air) or were inhibited by indomethacin (10`M). The efficacy and specificity of these inhibitory treatments were assessed with vasoactive agents whose action, with regard to endothelial mediation, has been determined previously. The arteriolar dilation maintained calculated wall shear stress close to control values during increases in flow and/or viscosity of the perfusate, but when the dilation was inhibited by removal of the endothelium or by indomethacin, wall shear stress increased significantly in a cumulative manner. We conclude that, in isolated arterioles of cremaster muscle, the dilation to increased flow (velocity) or viscosity of the perfusate is the result of an increase in shear stress that elicits the release of vasodilator prostaglandins from the
T he first experimental demonstration of arterial dilation after increases in blood flow was made by Schretzenmayr in 1933 . ' Interestingly, however, "flow-induced" dilation only recently gained attention again,2 10 perhaps because many other tissue parameters that change simultaneously with changes in blood flow could be held responsible for the ensuing vascular responses. Recent studies indicate that neither changes in metabolism of vascular or parenchymal tissues"1 nor changes in the pressure-sensitive myogenic response12 are responsible for the observed phenomenon. In most cases, the response of vessels to increases in flow is dilation; however, constriction was also observed. '3,14 This made it difficult to single out the underlying stimulus for the vascular response that is observed in response to an increase in blood flow.
In vivo studies demonstrated that, during the early phase of the flow increase, there is a period during which vascular diameter does not change; hence, the increase in flow is the result of an increase in flow velocity that consequently increases shear stress." [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] From the Department of Physiology, New York Medical College, Valhalla. Supported by National Institutes of Health grants HL-46813 and P01 HL-43023 and grant 89-062G from the American Heart This suggests that the increase in shear stress elicits dilation that, in turn, reduces shear stress, implying a causal relation between shear stress and dilation.4 '18 Another way to determine whether an increase in shear stress elicits dilation would be to increase the viscosity of the perfusate in the presence of constant flow. In acute in vivo experimental conditions, changes in the viscosity of blood, by varying the hematocrit, have not always resulted in consistent changes in blood flow.1920 In contrast, studies of large conduit arteries have indicated a direct relation between the viscosity of the perfusion solution or blood and vessel diameter in various experimental conditions, suggesting that an increase in shear stress, at the lumenal surface of the vessel, is the stimulus for the enhanced production of the factor(s) eliciting vasodilation.9,2' In the presence of constant pressure and flow, no data as yet have been obtained about viscosity-induced responses in single microvessels.
Studies of cultured vascular endothelial cells in which the simultaneous effect of ATP and shear stress was investigated suggested that flow-induced changes could perhaps be best explained by changes in mass transport of a dilator substance, the concentration of which could be increased during increases in blood flow at the boundary layer of the endothelial cell surface.22,23 By the same token, washout of vasoconstrictor substances from the environment of vascular tissue by an increase FIGURE 1. Illustration of experimental methods. The system contains two pressure transducers (PTs), each connected to a pressure-servo syringe, a flowmeter, and a flow transducer (FT) (see details in "Materials and Methods"'). The resistances of the primary (R1) and secondary (R2) pipette system are equal (R, =R2). in flow could also be hypothesized as being the cause of flow-dependent dilation.
The dilator factor(s) produced after an increase in flow has been shown, in most instances,16,24-30 to originate from endothelial cells; however, in some vessels it was found that the endothelium is not required to evoke relaxation of vascular smooth muscle.31 These disparate findings still leave doubt regarding the stimulus and the nature of the mediation of flow-dependent vascular responses. In addition, no in vitro data are available to support the conclusions of the in vivo observations of flow-dependent dilation in skeletal muscle arterioles. Therefore, the aim of the present study was 1) to test whether following an increase in flow a dilation is indeed evoked in isolated arterioles of cremaster muscle, 2) to test whether increases in shear stress induced by increases in the viscosity of the perfusate cause dilation in arterioles, 3) to demonstrate a role for the endothelium in the vascular response, and 4) to identify the mediator of the response.
Materials and Methods
Six-week-old male Wistar rats (average weight, 150 g) were anesthetized with intraperitoneal injections of sodium pentobarbital (Nembutal sodium solution, 50 mg/kg). The cremaster muscle was exposed by a median incision of the scrotal sac. The muscle was removed and then placed on a Petri dish containing cold (0-4°C) salt solution (pH 7.4). This solution contained (mM) NaCI 145, KCl 5.0, CaCl2 2.0, MgSO4 1.0, NaH2P04 1.0, dextrose 5.0, pyruvate 2.0, EDTA 0.02, and MOPS 3.0. The tissue was pinned to the silastic (transparent) bottom of the dish and allowed to equilibrate for 15 minutes. Rats were euthanatized by an overdose of sodium pentobarbital.
The isolation procedure of first-order arterioles was described previously.32 Briefly, with the use of microscissors and an operating microscope (Olympus Corp., Lake Success, N.Y.), segments of arterioles 1-2 mm in length were isolated from the cremaster muscle and surrounding tissue and transferred to the vessel chamber, which contained glass micropipettes and physiological salt (PS) solution at room temperature.
Both proximal (inflow) and distal (outflow) micropipettes were connected with silicone tubing to a pressure-servo syringe system (Living Systems Inc., Burlington, Vt.). The system was arranged to have mirror symmetry so that the axis of symmetry was located perpendicular to the middle of the arteriolar segment. This resulted in equal resistances of the two sides of the system (from pressure transducer to the tip of the pipette) ( Figure 1 ). Perfusion flow was established at a constant intravascular pressure (60 mm Hg) by changing the proximal and distal pressures to an equal degree but in opposite directions. The flow was measured by a ball flowmeter (Omega) in the range of 0-100 gl/min and was calibrated by a Harvard perfusion pump.
After the vessel was mounted on the primary pipette and secured with a suture, the pressure was raised to 20 mm Hg to flush and clear the vessel of clotted blood. Then the distal end of the arteriole was mounted to the outflow micropipette. After several minutes of perfusion, the distal outflow cannula was closed, and pressure was slowly increased to 60 mm Hg. Then the vessel was warmed slowly to 33°C and allowed to equilibrate for 60 minutes (YSI temperature controller, Yellow Springs Instrument Co., Yellow Springs, Ohio). The PS solution used in the chamber and for perfusion contained (mM) NaCl 110.0, KCl 5.0, CaCI2 2.5, MgSO4 1.0, KH2P04 1.0, dextrose 10.0, NaHCO3 24.0, and EDTA 0.02 at 21% 02-5% CO2 balanced with N2 and pH 7.4 (33°C). The volume of fluid in the vessel chamber and reservoir was 100 ml, and a constant rate of flow (40 ml/min) was maintained. The diameter of vessels in various experimental conditions was measured with a Vickers imageshearing device and recorded with an X-Y recorder (Omniscribe, Houston Instrument, Austin, Tex.).
Experimental Procedure
In the first series of experiments, after the equilibrium period, various flow rates were established in a stepwise manner by changing the inflow and outflow pressures, providing step increases in the pressure gradient. These flow rates were changed from 0 to 80 gl/min in 10-,ul/min steps. Each flow rate was maintained for 3-5 minutes to allow the vessel to reach a steady-state diameter. Flow-diameter relations were obtained in control conditions and after the endothelial cells of the arterioles were removed. In a separate group of arterioles, after obtaining control responses, indomethacin was administered, and flow-diameter relations were once more assessed.
In the second series of experiments, the viscosity of the perfusion solution was increased in a stepwise manner. The vessels were perfused with a PS solution containing 0%, 2%, 4%, or 6% dextran (molecular weight, 77,800) at a constant flow rate of 20 ,ul/min and in the presence of a constant perfusion pressure of 60 mm Hg. The 0%, 2%, 4%, and 6% dextran-PS solutions had a viscosity of 0.9, 1.35, 2.23 and 3.16 cp, respectively. These values were measured against water at 25°C in a viscometer. After obtaining the viscositydiameter relation, the endothelium of the arterioles was removed, and the experiments were repeated. In a separate group of arterioles, the experiments were repeated after indomethacin administration.
In the third series of experiments at flows of 20, 40, and 60 ,l/min, flow-diameter relations were obtained with perfusion solutions containing 0%, 2%, 4%, or 6% dextran. These experiments were repeated in the absence of the endothelium and also after indomethacin administration.
The vasodilator function of arteriolar endothelium and smooth muscle, before and after endothelium denudation, was assessed at 60 mm Hg perfusion pressure (no flow) with the use of test doses of acetylcholine (ACh, 5 x 10`M) and sodium nitroprusside (SNP, 5 x 10 8 M), which are known to be endothelium-dependent and -independent dilator agents, respectively.33 All drugs were added to the PS solution in the reservoir, and the final concentrations are reported. As described previously in detail,32 the endothelium was removed by perfusing the vessel with air. In this study, vessels were untied from the primary pipette, and the endothelium was removed by injection of 1 ml air into the lumen of the vessel through the distal pipette. The vessels were then reconnected to the primary pipette and filled with PS solution. They were then cleared of debris by perfusing them for 10 minutes at 20 mm Hg. The stopcock was then closed, and the intravascular pressure was raised to 60 mm Hg. The vessels achieved a steadystate tone (diameter) in approximately 30 minutes, whereupon responses to ACh and SNP were retested.
To inhibit the synthesis of prostaglandins, indomethacin (10-5 M) was added to the PS solution in the reservoir. Arteriolar dilation to arachidonic acid (10M ) and prostaglandin E2 (10`M) was used to test the efficacy and specificity of the inhibitor. 33 At the conclusion of the experiment, the perfusion solution was changed to a Ca2+-free PS solution that contained SNP (10`M) and EGTA (1.0 mM). Vessels were incubated for 10 minutes before determining their passive diameter at a perfusion pressure of 60 mm Hg. Preliminary experiments showed that the vasoactive function of vessels was maintained up to 4-5 hours, as indicated by the presence of repeatable arteriolar responses to increases in flow, viscosity, and vasoactive agents.
In control conditions and after each flow or viscosity step, when a steady-state diameter was achieved, shear stress (r) was calculated as follows: sr=4sqQ/l7-r3, where sq is viscosity, Q is blood flow, and r is vessel radius. All salts and chemicals were obtained from Sigma Chemical Co., St. Louis, Mo., or Aldrich Chemical Co., Milwaukee, Wis., and were prepared on the day of the experiment. The data are presented as mean±SEM. Differences were considered significant at p<0.05 and were determined by analysis of variance followed by a post hoc multiple-comparison test and paired Student's t 
Results
The arterioles developed spontaneous tone (80±+1.2 gm) in response to an intravascular pressure of 60 mm Hg. To assess the active tone generated by the myogenic activity of arterioles in response to intravascular pressure, the passive diameter of arterioles (156± 1.8 gum) was also obtained at 60 mm Hg in the absence of Ca2+ in the perfusion solution.
The presence of functional endothelium was assessed by the dilation of the arterioles in response to ACh and SNP33 (Table 1 ). In the control condition, before endothelial denudation, ACh (5 x 10`8 M) and SNP (5 x 10 8 M) caused significant dilation (an increase of approximately 40% of the basal diameter) of vessels. After removal of the endothelium, dilation in response to ACh was completely abolished, whereas the response to SNP was not significantly altered ( Table 1 ). Figure 2A shows that the diameter of arterioles is increased in response to stepwise increases in perfusate flow in the presence of endothelium. The step increases in flow (10 ,ul/min) from 0 to 80 gul/min elicited, with a delay of 21.7±2.0 seconds (range, 7-51 seconds; n=30), continuous increases in vessel diameter from :80 to 120 ,um. The new steady-state diameter in response to each step increase in flow developed within 2-3 minutes. Above 60 ,ul/min, further increases in perfusate flow did not change the diameter significantly.
Effect of Increases in Flow on Arteriolar Diameter
After removal of the endothelium, step increases in perfusate flow were repeated, and the changes in arteriolar diameter were again followed. We found that removal of the endothelium did not significantly affect the development of an active spontaneous tone in response to a perfusion pressure of 60 mm Hg. However, there was no dilation in response to increases in perfusate flow (Figure 2A ), indicating that the sensitivity of vessels to increases in flow was lost after endothelium removal.
At each flow step, shear stress was calculated in the presence and absence of endothelium. After the removal of the endothelium, each step increase in flow test, as appropriate.
elicited an increase in shear stress . Figure 2B) ; thus, increases in perfusate flow from 0 to 80 ,ul/min elicited corresponding increases in shear stress from 0 to 470 dyne/cm2. When the endothelium was present, however, shear stress changed only from 0 to =90 dyne/cm2 through the entire flow range ( Figure 2B ). This finding strongly suggests that the independent variable that regulates vessel diameter is not flow but shear stress. To further explore this hypothesis, the relation between increases in shear stress and diameter was also obtained ( Figure 2C ). During steady-state conditions, in the presence of endothelium, there was a significant increase in diameter from n:80 to =120 gim in response to increases in shear stress from 0 to t90 dyne/cm2. In contrast, after removal of the endothelium, shear stress increased significantly in a cumulative manner because vessel diameter did not change.
To elucidate the nature of the endothelial factor(s) that mediates arteriolar dilation in response to flow, indomethacin was administrated in the second series of experiments after a control flow-diameter relation was obtained. The efficacy of the inhibition of prostaglandin synthesis by indomethacin was indicated by the complete loss of arteriolar dilation to arachidonic acid while the dilation to prostaglandin E2 remained unaffected (Table 1 ). We found that indomethacin almost completely inhibited arteriolar dilation after the increases in flow of the perfusion solution ( Figure 3A) . After inhibition of prostaglandin synthesis, the relation between flow rate versus shear stress and shear stress versus diameter was similar to that obtained after removal of the endothelium (Figures 3B and 3C , respectively).
Effect of Increases in Perfusate Viscosity on Arteriolar Diameter
In a separate series of experiments, viscosity-diameter relations of arterioles were obtained with the perfusion solution containing 0%, 2%, 4%, and 6% dextran at a constant 20-pgl/min perfusate flow and a constant 60 mm Hg perfusion pressure ( Figure 4A ). In these conditions, increases in viscosity of the perfusion solution from 0.9 to 3.16 cp elicited corresponding significant increases in arteriolar diameter from -95 to z118 gim. After removal of the endothelium, however, the in- creases in viscosity of the perfusion solution did not elicit changes in arteriolar diameter ( Figure 4A ). Shear stress increased significantly with increased viscosity of the perfusion solution only in endothelium-removed arterioles. In the presence of endothelium, the increase in diameter prevented the substantial increase in shear stress (Figures 4B and 4C) . The above experimental protocols were repeated in vessels in which prostaglandin synthesis was inhibited by indomethacin. In these arterioles, the increases in the viscosity of the perfusate again did not evoke dilation ( Figure 5A ). Therefore, a significant gradual increase in . This increase in shear stress was the result of the absence of an increase in diameter as shown in Figure SC . It is of note that in these conditions the difference in control diameter between vessels with and without endothelium (or after indomethacin) was due to the presence of constant flow (20 gl/min), which, as we showed above (Figures 2A and 3A) , elicits an increase in shear stress and release of mediator(s) from the endothelium.
Combined Effect of Flow and Viscosity on Arteriolar Diameter
In a separate group of arterioles, we have studied the effects on vascular diameter and shear stress of changes in viscosity of the perfusion solution at different flow rates. The active flow-diameter curve obtained with increasing concentrations of dextran in the perfusate was shifted upward in the presence of endothelium (Figures 6A and 7A ). Calculation of shear stress in control conditions and after dilation of arterioles indicated that in the presence of endothelium the gradual increase in arteriolar dilation to increases in the viscosity and/or flow of the perfusate prevented great increases in shear stress ( Figure 6B ). The relations be- tween flow rate and shear stress, which were obtained after removal of the endothelium (Figures 6A and 6B ) or inhibition of prostaglandin synthesis by indomethacin ( Figures 7A and 7B) , showed that in these conditions arteriolar dilation was abolished; hence, significant increases in shear stress in response to simultaneous increases in viscosity and flow were observed.
Discussion
The present study demonstrates that, in the absence of any dilator substance in the perfusion solution, isolated pressurized arterioles (-80 ,um) from rat cremaster muscle dilate in response to increases in perfusate flow (velocity) or viscosity. The data also strongly suggest that the underlying stimulus for flow-dependent and viscosity-dependent dilation is the increase in wall shear stress. The factor(s) responsible for mediating shear stress-induced dilation is prostanoid in nature and is produced in the arteriolar endothelium.
Schretzenmayr1 originally suggested local reasons for arterial dilation after increases in flow. After the early descriptions of the experimental phenomenon, however, because of the complex in vivo conditions, factors other than a local increase in blood flow were also hypothesized as being responsible for the arterial dilation. Hilton2 assumed that a "conducted" stimulus originating from parenchymal tissues evoked the vascular response. Later, Rodbard4 hypothesized a role for an increase in shear stress at the vascular wall in the diameter changes to increases in flow. Much effort was also directed toward avoiding changes in intravascular pressure3'5 and metabolism of parenchymal and vascular tissues at a time when changes in flow (velocity) occur16 in order to exclude these parameters as possible stimuli for the observed dilation. Recent studies demonstrated the existence of flow-dependent dilation in various vascular beds in vivo15-7 and in vitro,3-10.24-30,34.35 but the possible role and participation of factors that could initiate the vascular response after changes in blood flow could not always be clearly elucidated.
Interestingly, it has also been reported that, in vitro, some vessels respond with constriction to saline infusion into the open end of the vessel's ring.13 Also, in perfused isolated rabbit femoral artery, an inverse relation was found between flow and diameter.'4 The reason for some studies showing vessel constriction and others showing vessel dilation after increases in flow remains obscure. One could speculate that the differences might be due to differences in species, in the function of the various segments of the organs' vasculature, or in the methods used to examine this vascular response.
To avoid the interference of changes in diameter due to the pressure-induced myogenic response, in the present experiments intravascular pressure was measured and maintained constant during increases in flow or viscosity at a value similar to that measured in arterioles in vivo. Also, the stable environment provided a steady-state metabolism of vascular tissue. Therefore, we concluded that the dilation that was observed was related to the increased flow itself. However, in the present and previous experiments with skeletal muscle arterioles,15,16 it was observed that increases in flow did not elicit vascular dilations immediately. In the period between the onset of the increase in flow and the ensuing vasodilation (7-51 seconds), there occurs an increase in flow velocity in the presence of a constant diameter, which elicits a proportional increase in wall shear stress, which is calculated as iqdv/dr, where qj is viscosity, v is velocity, and r is radius. To elucidate the underlying stimulus for the arteriolar dilation in response to changes in flow or viscosity, we analyzed the relation between changes in calculated shear stress and diameter in steady-state conditions. We found that, in the presence of endothelium, when increases in flow were followed by dilation, there were no great increases in wall shear stress. In contrast, in the absence of endothelium or endothelial prostaglandins, when the increases in flow were not followed by dilation, shear stress increased linearly to extreme values as a function of flow. These findings indicate a causal relation between changes in shear stress and diameter and the presence of an endothelial mechanism that senses and maintains shear stress, in a negative feedback manner, close to the control condition. Despite increases in diameter, shear stress increased slightly with increases in flow, suggesting that perhaps this degree of elevation in shear stress provides the stimulus for the enhanced synthesis of factors to maintain dilation (Figures 3-5) .
Recently, in tissue culture studies, measurements of no changes in the Ca`signal, which could be associated with dilation36 after increases in shear stress, unless ATP or another agonist had been present.22,23 Therefore, it was proposed that an increase in mass transport due to changes in blood (or perfusate) flow could significantly affect the delivery (or washout) of vasoactive substances at the boundary layer of the endothelial cell membrane, which in turn could affect the production of endothelial factors.22,23 Because in our experiments the solution used to perfuse the arterioles did not contain vasoactive agents, mass transport of circulating substances is unlikely to have played a role, indicating that it is the increase in shear stress during the period when the increase in diameter lags behind the increase in flow that induces the vasodilation. Nevertheless, to eliminate completely the possible effects of mass transport-related changes in arteriolar diameter after increases in flow and to clearly demonstrate the role of shear stress in flow-dependent dilation, we next studied the vascular effects of increases in perfusate viscosity in the presence of a constant perfusate flow. An increase in viscosity of the perfusion solution at constant perfusate flow (and pressure) provided a steady-state condition of mass transport of solvents to (or out of) the vascular tissue, yet it increased wall shear stress proportionately. We found that increases in shear stress due to the increases in viscosity of the perfusion solution resulted in arteriolar dilation quite similar to that which followed the increases in flow velocity. A similar idea was suggested by studies of femoral20 21 2737 and mesenteric9,29 arteries in which viscosity of the perfusion solution or blood was varied, although in larger vessels, during high flow conditions, the return of shear stress to control is not complete because of the lesser capacity of large arteries to dilate.
Our next study was based on the hypothesis that if both flowand viscosity-induced dilation are dependent on increases in shear stress, then simultaneous increases in flow and viscosity of the perfusate should elicit an enhanced additive dilation. Indeed, we found an upward shift of the flow-diameter curves with increasing viscosity of the perfusate (Figures 6 and 7) . Also, in the absence of endothelium or prostaglandins, wall shear stress reached a much higher value than that observed with flow or viscosity alone. These findings further confirm the notion that both flow (velocity)-induced and viscosity-induced dilations are initiated by an increase in wall shear stress.
Although flow-dependent dilation is likely to be a more complex phenomenon in vivo than in vitro and is perhaps mediated by more than one mechanism, the above findings argue against mass transport of vasoactive substances as a prerequisite for flow (shear stress)-dependent vascular responses. This idea is supported by theoretical considerations as well. In theory, if dilation were due solely to an increase in mass transport, then flow-induced dilation would be a positive feedback phenomenon, and it would not cease until complete dilation is achieved. However, previous in vivo15-8 and the present in vitro study indicate that, after normalizing arteriolar shear stress, diameter does not increase further, demonstrating that the error signal is regulated via a negative feedback mechanism, as proposed previously.415 18, 38 It is of note that in the present study, in the presence intracellular Ca2`by fluorescence techniques revealed of endothelium, the values of wall shear stress that were maintained during increases in flow or viscosity of the perfusion solution are in close agreement with those of in vivo microcirculatory studies (50-80 dyne/cm2).39 Also, the changes in viscosity (-1-3 cp) in our study were in a range that could elicit diameter changes via changes in shear stress in vivo, suggesting an important role for blood viscosity in the regulation of resistance and, hence, in blood flow and pressure distribution in microvascular networks. In vivo, viscosity can change because of variations in hematocrit, which, via changes in wall shear stress, can induce changes in diameter and resistance. Therefore, when analyzing the causes that alter resistance during changes in hematocrit, one should take into account, in addition to the factors previously described,3940 the shear stress (viscosity)induced changes in diameter, as well.
In the present study, removal of the endothelium abolished arteriolar dilation to both flow and viscosity, eliciting a cumulative increase in shear stress (Figure 4 ). This in vitro finding is consistent with our previous in vivo results that demonstrated a similar shear stress sensitivity of arterioles of the cremasteric microcirculation mediated by endothelial factors.1618 These findings are also in agreement with those obtained by Kuo et al28 in pig coronary arterioles and by Randall and Griffith35 in rabbit ear arteries in situ and with studies on iliac,8 femoral,24-27 mesenteric,9'29 and coronary1034 arteries, vessels in which the dilation after flow increases is dependent on the endothelium. In most of these vessels, the use of hemo-globin34 35or an L-arginine analogue29,35,41 abolished flowdependent dilations. Also, cultured bovine thoracic aorta endothelial cells release an L-arginine-dependent vasodilator factor in response to shear stress.42 Therefore, it seems that in these vessels endothelium-derived relaxing factor (nitric oxide) mediates the flow-induced dilation; however, in most of the studies, indomethacin was used throughout the experiment, which prevented the evaluation of the role of prostaglandins, which also can be released from microvascular endothelial cells in response to shear stress.
Indeed, in the present study indomethacin completely inhibited shear stress-induced dilation and consequently we concluded that shear stress-dependent responses in cremasteric arterioles are primarily (if not exclusively) mediated by prostaglandins, most likely prostaglandin E2 and prostaglandin I2.43 This conclusion is further supported by our previous in vivo finding that NG-methyl-Larginine, an inhibitor of nitric oxide synthase, did not affect the shear stress-induced dilation, which was, however, completely inhibited by indomethacin and meclofenamate.44 The role of prostaglandins in the mediation of flow-dependent dilation is suggested by other studies as well. For example, in cultured endothelial cells, prostacycin is released after increases in shear stress,45 46 whereas Quadt et a147 showed similar results in response to pulsatile flow in the rat aorta.
All of these findings indicate that shear stress-dependent dilation can be mediated by prostaglandins and/or nitric oxide, but they do not exclude the possibility of a role for other endothelial30 or nonendothelial media-tors31'42 participating in different proportions in different vascular beds. Because of the inadequate number of studies, however, one cannot as yet draw definitive conclusions regarding the role of these factors in the mediation of shear stress-dependent dilation in the It has recently been reported that cultured human umbilical vein endothelial cells release ATP, ACh, and substance P in response to increases in flow.48 On the basis of these studies, one can speculate that these dilator factors released from endothelial cells in response to shear stress could stimulate endothelial cells in an autocrine or paracrine fashion to synthesize and release mediators, such as prostaglandins or other endothelium-derived factors, resulting in dilation of the same or downstream segments of the vessel.
The finding that arterioles are sensitive to changes in shear stress requires a reevaluation of the role and interaction of local factors in the regulation of microcirculation. It is likely that in many cases changes in pressure and/or diameter result in changes in the velocity of blood flow in microvascular networks. Also, temporal and spatial variations in hematocrit and plasma constituents can elicit corresponding changes in viscosity. Changes in both velocity of flow and viscosity via alterations in shear stress will then affect the diameter of the vessels modifying their primary response to changes in pressure or metabolic factors. The actual resistance in the vasculature of an organ will depend on the sum of the various regulatory mechanisms,49 the proportional participation of which could be different in the development of basal vascular tone and in autoregulatory reactions, such as reactive and functional hyperemia, as well as during collateral blood flow development or during changes in blood pressure and blood flow.
Several physiological functions of the shear stresssensitive regulation in arterioles could be envisioned: 1) to protect the endothelium from large changes in shear stress, believed to have adverse effects on the endothelium; 2) to promote and maintain dilation during high flow (and pressure) conditions, thereby counteracting myogenic (and other) constrictor mechanisms, which otherwise could lead to the elevation of systemic pressure; 3) to maintain a constant pressure drop across vascular networks to provide steady-state conditions for capillary fluid exchange; and 4) to optimize the energy loss in the circulation, an important aspect of circulatory homeostasis emphasized by previous theoretical studies. 50 All these functions seem to impart an important role for the shear stress-sensitive mechanism in the autoregulation of organ blood flow in skeletal muscle microcirculation besides the previously established myogenic and metabolic mechanisms.
In summary, the present study demonstrates that in single arterioles the underlying stimulus that evokes flowdependent or viscosity-dependent dilation is the increase in wall shear stress. Furthermore, we found that the steady-state diameter of isolated cremasteric arterioles is regulated by shear stress in a negative feedback manner. The mediator in the cremasteric circulation of rats, which elicits arteriolar dilation in response to increases in shear stress, is endothelium-derived prostaglandins.
